You are invited to the inauguration of the IRCM Rare Kidney Diseases Clinic of the IRCM’s Center for Research on Rare and Genetic Diseases in Adults in the presence of Dr. Yves Berthiaume, IRCM Vice-President, Clinical and Clinical Research of the Institute and Dr. Guillaume Bollée, Director of the new clinic.
Following the inauguration, we will present our second Science Café, "Polycystic Kidney Disease (PKD): Understanding the genetic, psychological and social implications of a diagnosis". Featuring a panel of local experts to highlight the close reality of PKD and the strengths of the local community, this Science Café will include short presentations with the opportunity for questions from the audience.
Note: Paid parking is available at the former Hôtel-Dieu site opposite the IRCM.
Please RSVP for this free event below the list of speakers!
SCIENCE CAFÉ SPEAKERS & TOPICS
Dr. Marie Trudel, PhD
Topic: Understanding polycystic kidney disease in mice to design and test novel therapies
- Human ADPKD genetic and overview of the disorder
- What we know about cyst formation and progression
- Characterization of ADPKD mouse models in comparison to human
- Study on the mechanism of cyst growth and expansion in PKD kidneys and liver
- What mechanism can delay or stop cyst or PKD most efficiently?
Dr. Guillaume Bollée, PhD
Topic: The changing face of polycystic kidney disease and the need for a new model of care
Summary: Recent years have witnessed important changes in the management of polycystic kidney disease (PKD) with the improvement of our understanding of the disease, better delineation of the risk of progression and the emergence of targeted therapies. These advances hold promise for patients and their families, but also make care increasingly sophisticated. A multidisciplinary specialized approach, involving physicians and healthcare professionals, is becoming necessary to provide best care for PKD. The participation of patient groups to research projects is also of paramount important to develop new therapeutic strategies in the long term. To address these challenges, it becomes necessary to build a new patient-centric healthcare model. The creation of a reference centre, providing access to specialized care and promoting research represents a unique opportunity to improve outcomes and stop PKD.
Dr. Gail Ouellette, PhD
Topic: Genetic counselling and genetic testing for polycystic kidney disease
Genetic counselling aims at giving you accurate and up-to-date information to understand your disease and your different options. Genetic tests can be done to confirm your diagnosis, to test other members of your family or to help you make choices in planning for a future family. I will present the “why, where, when and how” of all existing options.
Rosa Caporicci, MA (C. Psy)
Topic: Understanding the emotional impacts of a PKD diagnosis
A focus on the psychological and social implications of a PKD diagnosis and its effect on relationships and the search for comprehension and acceptance. While the presentation will be offered in English, I will be pleased to take questions in English or French.